Viridian Therapeutics, Inc. VRDN
28.55 USD -0.50 (-1.74%)
At closeNov 5, 2026, 7:30 PM EST
29.56 +1.01 +3.54%
After hours · Nov 5, 7:30 PM ET
28.48 Day range 29.61
13.18 52-week range 34.29
- YTD
- -8.26%
- 1 year
- +16.91%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 70.85M | 302.00K | 314.00K | 1.77M | 2.96M | |
| 70.85M | 302.00K | 314.00K | 1.77M | 2.96M | |
| -363.39M | -299.04M | -254.45M | -134.30M | -79.73M | |
| -342.60M | -269.95M | -237.73M | -129.87M | -79.41M | |
| -3.32 | -3.07 | -3.91 | -2.71 | -6.66 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 212.38M | 99.59M | 102.83M | 155.58M | 42.30M | |
| 899.42M | 742.40M | 490.42M | 435.09M | 203.71M | |
| 177.25M | 70.76M | 48.40M | 40.03M | 15.99M | |
| 84.18M | 20.58M | 20.20M | 4.64M | 0 | |
| 722.17M | 671.64M | 442.02M | 395.06M | 187.72M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -276.39M | -232.32M | -184.17M | -93.84M | -54.58M | |
| -37.56M | -228.65M | -94.25M | -115.13M | -74.29M | |
| 426.74M | 457.74M | 225.67M | 322.24M | 125.28M | |
| -495.00K | -511.00K | -898.00K | -797.00K | -259.00K | |
| 112.79M | -3.23M | -52.75M | 113.28M | -3.60M |